These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8649292)

  • 1. Managing HIV. Part 5: Treating secondary outcomes. 5.15 HIV and non-tuberculous mycobacterial infection.
    Hoy JF; Marriott D; Gottlieb T
    Med J Aust; 1996 May; 164(9):543-5. PubMed ID: 8649292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nontuberculous mycobacteriosis; the present status and in the future. Infection with human immunodeficiency virus (HIV) and nontuberculous mycobacteriosis].
    Mizutani S
    Kekkaku; 1998 Feb; 73(2):87-92. PubMed ID: 9545702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with rifabutin in the treatment of mycobacterial infections.
    De Cian W; Sassella D; Wynne BA
    Scand J Infect Dis Suppl; 1995; 98():22-6. PubMed ID: 8867175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection].
    Payen MC; De Wit S; Clumeck N
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S142-51. PubMed ID: 9496599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS.
    Cohn DL; Fisher EJ; Peng GT; Hodges JS; Chesnut J; Child CC; Franchino B; Gibert CL; El-Sadr W; Hafner R; Korvick J; Ropka M; Heifets L; Clotfelter J; Munroe D; Horsburgh CR
    Clin Infect Dis; 1999 Jul; 29(1):125-33. PubMed ID: 10433575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
    Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
    J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of Mycobacterium avium-intracellulare Complex in infections (review of the literature)].
    Filipovskiĭ AV
    Probl Tuberk; 1999; (5):45-8. PubMed ID: 10565219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic antibiotic receives speedy FDA approval to reduce MAC disease in advanced HIV.
    AIDS Patient Care STDS; 1996 Dec; 10(6):379. PubMed ID: 11361569
    [No Abstract]   [Full Text] [Related]  

  • 9. Uveitis associated with rifabutin therapy: a clinical alert.
    Petrowski JT
    J Am Optom Assoc; 1996 Nov; 67(11):693-6. PubMed ID: 8979664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifabutin levels may increase with fluconazole during MAC treatment.
    AIDS Patient Care STDS; 1996 Oct; 10(5):310. PubMed ID: 11361528
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical manifestations and treatment of mycobacterium avium-intracellulare complex infection in HIV-infected patients.
    Julander I
    Scand J Infect Dis Suppl; 1995; 98():19-20. PubMed ID: 8867173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and treatment of tuberculosis or Mycobacterium avium-intracellulare complex infection in HIV-infected patients].
    Shirasaka T
    Kekkaku; 2007 Nov; 82(11):845-8. PubMed ID: 18078110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new prophylactic agent in AIDS: Ansatipine. Disseminated Mycobacterium avium complex infection is now the most frequent of the opportunistic bacterial infections in AIDS].
    Dautzenberg B
    Allerg Immunol (Paris); 1994 Apr; 26(4):141-4. PubMed ID: 8031459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated Mycobacterium avium complex infection: implications of recent clinical trials on prophylaxis and treatment.
    Benson CA
    AIDS Clin Rev; 1997-1998; ():271-87. PubMed ID: 9305452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifabutin for MAC questioned.
    Posit Aware; 1995; ():6. PubMed ID: 11362571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium avium complex infection in HIV/AIDS patients.
    Corti M; Palmero D
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):351-63. PubMed ID: 18588499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of mycobacterial infections in patients with HIV/AIDS].
    Pulido F; Iribarren JA; Kindelan JM; Moreno S
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():20-8. PubMed ID: 9859616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV: opportunistic infections.
    Ioannidis J; Wilkinson D
    Clin Evid; 2003 Jun; (9):795-816. PubMed ID: 15366175
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
    Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR
    Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Criteria for use of rifabutin in adult patients with human immunodeficiency virus (HIV)-associated disease.
    Fish N; Kass CL
    Am J Health Syst Pharm; 1996 Jul; 53(13):1598-9. PubMed ID: 8809283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.